cilastatin
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
2 FDA-registered drug labelers
ACS Dobfar S.p.A
Merck Sharp & Dohme LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Recarbrio
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Imipenem and Cilastatin Injection
01/08/2026Chemical Identity
CAS82009-34-5
PubChem CID6435415
DTXSIDDTXSID8048238
FormulaC16H26N2O5S
Mol. Weight358.5 g/mol
SMILESCC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C
Data Sources
64354152026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/cilastatin/cids/JSON
Archive: data/sources/pubchem_name/cilastatin.json
CAS 82009-34-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 82009-34-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json